Covaxin, bharat biotech, sec, covid 19, bharat biotech s covaxin, india, DCGI, Covaxin for emergency use in age group between 6-12 years, CDSCO, Hyderabad, Zydus Healthcare, Bharat Biotech, National Technical Advisory Group on Immunisation, Astra Zeneca vaccine, Covishield, Bharat Biotech, india
India News: Lav Agrawal, Union health ministry joint secretary, on Friday, said India has to buy time to ensure high coverage of vaccination against Covid-19. He
India News: NEW DELHI: Data sharing is going on with WHO to give recognition to Bharat Biotech's Covaxin, the government said, noting that it wants to achieve thi.
IIL to produce drug substance for Covaxin
May 28, 2021
IIL is expected to produce the drug for about 10-15 million doses per month Indian Immunologicals Ltd (IIL) is planning to start the production of drug substance for Bharat Biotech’s Covaxin, from June 15.
The first batch of the drug will be sent to Bharat Biotech by July, K Anand Kumar, Managing Director, IIL, said in a release issued here on Friday.
IIL is expected to produce the drug for about 10-15 million doses per month. Initially, it will produce for 2-3 million doses and it will be scaled up to 6-7 million per month later in the year, Kumar said.